Click on a program title below to view the on-demand webcast. CME and/or CNE accreditation has expired for archived programs.

ASM 2016 screenshot

Predicting Infections in Transplant Patients: Cellular Immune Assays for Tuberculosis and CMV

This program is intended for physicians, scientists, nurses, microbiologists, and pharmacists who are interested in the clinical and research aspects of microbiology and its applications in solid organ and tissue transplantation. It reviews the importance of screening for TB in transplant patients and explores the use of cellular immune assays to identify patients at risk of developing CMV post-transplant. Clinical case studies are presented to discuss the use of this information as part of a patient's overall clinical picture.
  • Presented by:
  • Roy F. Chemaly, MD, MPH, FIDSA, FACP
  • Raymund R. Razonable, MD

Breaking Down Barriers in TB Screening for the Transplant Patient

This program provides a comprehensive overview for clinicians about how to evaluate all of the considerations that are associated with TB screening of both recipient and donor patients, and the impact of TB test results on clinical management before and after transplant.
Presented by:
  • Camille Nelson Kotton, MD, FIDSA
  • Deepali Kumar, MD, MSc, FRCPC
  • Prof. Dr. Martina Sester, PhD
igra kumar screenshot 2015

Clinical Utility of CMV-specific IGRAs for Determining Protection Against CMV

This program is intended for physicians, surgeons, scientists, nurses, organ procurement personnel and other healthcare professionals interested in the clinical and research aspects of solid organ and tissue transplantation. At the end of this activity, participants should be able to determine the epidemiology and incidence of CMV infection in immunocompromised patients, discuss new data on the role IGRAs may play in the prediction of CMV infection, and describe the clinical value of IGRAs on pre-emptive or prophylaxis strategies for CMV.
Presented by:
  • Deepali Kumar, MD, MSc, FRCPC
igra Chemaly Screenshot 2015 final

The Challenges and Pitfalls in Diagnosing or Misdiagnosing Tuberculosis in Transplant Recipients

The goal of this activity is to convey information to physicians and health care professionals in the field of transplantation and to encourage group participation and discussion. At the end of this activity, participants should be able to determine the epidemiology and incidence of TB infection in immunocompromised patients, differentiate between the 3 available latent TB testing methods, and identify the clinical utility of IGRAs when testing immunocompromised patients for TB.
Presented by:
  • Roy Chemaly, MD, MPH, FIDSA, FACP
ATC 2016

Predicting Infections in Transplant Patients: Cellular Immune Assays for Tuberculosis and CMV

This program is intended for physicians, surgeons, scientists, nurses, organ procurement personnel, and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. It reviews the importance of screening for TB in transplant patients and explores the use of cellular immune assays to identify patients at risk of developing CMV post-transplant. Clinical case studies are presented to discuss the use of this information as part of a patient's overall clinical picture.
  • Presented by:
  • Roy F. Chemaly, MD, MPH, FIDSA, FACP
  • Camille Nelson Kotton, MD, FIDSA
Back to Top